Therefore, the aberrant activation of the PI3K/AKT/mTOR and/or MAPK/ERK pathways observed in uterine SIL or SCC [185,186] is most likely due to the concurrent activities of inflammatory mediators, growth factors, and HR-HPV oncoproteins. The gene discussed is AKT1; the disease is squamous cell intraepithelial neoplasia.